輸入代號或公司名稱後按 Enter
1731

美吾華

-0.10 (-0.48%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
20.8068成交張數13.77本益比1.26股價淨值比5.87%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.5233.3%1.520.6816.9%3.09%9.53%
2026Q10.437.5%1.390.5812.8%2.63%8.45%
2025Q40.2623.8%1.360.358.5%1.66%8.48%
2025Q30.313.3%1.310.4010.8%1.95%8.40%
2025Q20.3911.4%1.300.5214.0%2.49%8.59%
2025Q10.40-9.1%1.260.5312.6%2.48%7.86%
2024Q40.210.0%1.300.297.7%1.39%8.36%
2024Q30.300.0%1.300.3911.2%1.93%8.47%
2024Q20.35-2.8%1.300.4713.4%2.28%8.69%
2024Q10.4410.0%1.310.5814.2%2.79%8.36%
2023Q40.2123.5%1.270.298.5%1.41%8.38%
2023Q30.30-11.8%1.230.4013.1%2.00%8.17%
2023Q20.365.9%1.270.4815.2%2.39%8.61%
2023Q10.408.1%1.250.5315.3%2.60%8.03%
2022Q40.1713.3%1.220.227.1%1.11%8.09%
2022Q30.340.0%1.200.4514.6%2.31%8.14%
2022Q20.34-15.0%1.200.4515.6%2.29%8.04%
2022Q10.375.7%1.260.5014.6%2.44%8.36%
2021Q40.157.1%1.240.205.9%0.99%8.47%
2021Q30.34-8.1%1.230.4513.2%2.25%8.62%
2021Q20.40-21.6%1.260.5417.3%2.69%8.72%
2021Q10.3529.6%1.370.4614.9%2.40%9.66%
2020Q40.14600.0%1.290.197.0%1.01%9.41%
2020Q30.3776.2%1.170.4816.5%2.67%8.66%
2020Q20.51131.8%1.010.6728.2%3.80%7.62%
2020Q10.27-12.9%0.720.3713.8%2.07%5.38%
2019Q40.020.760.031.1%0.16%5.79%
2019Q30.21-12.5%0.670.2710.4%1.55%5.09%
2019Q20.2215.8%0.700.2910.4%1.66%5.41%
2019Q10.3147.6%0.670.4213.3%2.40%5.01%
2018Q4-0.07-200.0%0.57-0.09-3.3%-0.53%4.36%
2018Q30.24-11.1%0.710.3211.8%1.83%5.39%
2018Q20.1926.7%0.740.259.2%1.42%5.74%
2018Q10.2131.3%0.700.289.3%1.59%5.23%
2017Q40.07-66.7%0.650.092.3%0.51%4.93%
2017Q30.273.9%0.790.368.7%2.10%6.10%
2017Q20.1536.4%0.780.194.9%1.13%6.15%
2017Q10.1660.0%0.740.215.7%1.23%5.63%
2016Q40.210.680.287.4%1.65%
2016Q30.260.359.3%2.05%